# Investar Holding Corp: financial statements, quarterly

ISTR · Nasdaq · CIK 1602658 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/istr.md) · [Financials](/companies/istr/financials.md) · [Filings](/companies/istr/filings.md) · [Insiders](/companies/istr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/istr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [19.1](/filings/0001437749-24-033826.md) | [19.8 d](/filings/0001437749-26-008446.md) | [21.4](/filings/0001437749-25-015124.md) | [20.4](/filings/0001437749-25-025103.md) | [22.3](/filings/0001437749-25-033373.md) | [23.3 d](/filings/0001437749-26-008446.md) | [24.0](/filings/0001437749-25-015124.md) | [22.1](/filings/0001437749-25-025103.md) | [24.0](/filings/0001437749-25-033373.md) | [23.5 d](/filings/0001437749-26-008446.md) | not reported | not reported |
| Interest expense | $m | [15.7](/filings/0001437749-23-030040.md) | [18.2 d](/filings/0001437749-24-006962.md) | [18.5](/filings/0001437749-24-014351.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.6](/filings/0001437749-24-033826.md) | [0.8 d](/filings/0001437749-26-008446.md) | [1.4](/filings/0001437749-25-015124.md) | [0.8](/filings/0001437749-25-025103.md) | [0.8](/filings/0001437749-25-033373.md) | [1.2 d](/filings/0001437749-26-008446.md) | [1.4](/filings/0001437749-26-015924.md) | [0.9](/filings/0001437749-26-026348.md) | [1.3](/filings/0001437749-25-033373.md) | [1.3 d](/filings/0001437749-26-008446.md) | [2.9](/filings/0001437749-26-015924.md) | [2.1](/filings/0001437749-26-026348.md) |
| Net income | $m | [2.8](/filings/0001437749-24-033826.md) | [3.5 d](/filings/0001437749-26-008446.md) | [4.7](/filings/0001437749-25-015124.md) | [4.1](/filings/0001437749-25-025103.md) | [5.4](/filings/0001437749-25-033373.md) | [6.1 d](/filings/0001437749-26-008446.md) | [6.3](/filings/0001437749-26-015924.md) | [4.5](/filings/0001437749-26-026348.md) | [6.2](/filings/0001437749-25-033373.md) | [5.9 d](/filings/0001437749-26-008446.md) | [12.0](/filings/0001437749-26-015924.md) | [9.5](/filings/0001437749-26-026348.md) |
| Diluted EPS | $ per share | [0.28](/filings/0001437749-24-033826.md) | not reported | [0.48](/filings/0001437749-25-015124.md) | [0.41](/filings/0001437749-25-025103.md) | [0.54](/filings/0001437749-25-033373.md) | not reported | [0.63](/filings/0001437749-26-015924.md) | [0.46](/filings/0001437749-26-026348.md) | [0.54](/filings/0001437749-25-033373.md) | not reported | [0.77](/filings/0001437749-26-015924.md) | [0.61](/filings/0001437749-26-026348.md) |
| Basic EPS | $ per share | [0.28](/filings/0001437749-24-033826.md) | not reported | [0.48](/filings/0001437749-25-015124.md) | [0.41](/filings/0001437749-25-025103.md) | [0.55](/filings/0001437749-25-033373.md) | not reported | [0.64](/filings/0001437749-26-015924.md) | [0.46](/filings/0001437749-26-026348.md) | [0.57](/filings/0001437749-25-033373.md) | not reported | [0.84](/filings/0001437749-26-015924.md) | [0.64](/filings/0001437749-26-026348.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,790](/filings/0001437749-23-030040.md) | [2,815](/filings/0001437749-25-007226.md) | [2,788](/filings/0001437749-24-014351.md) | [2,788](/filings/0001437749-24-024247.md) | [2,803](/filings/0001437749-24-033826.md) | [2,723](/filings/0001437749-26-008446.md) | [2,730](/filings/0001437749-25-015124.md) | [2,748](/filings/0001437749-25-025103.md) | [2,801](/filings/0001437749-25-033373.md) | [2,833](/filings/0001437749-26-026348.md) | [3,875](/filings/0001437749-26-015924.md) | [3,862](/filings/0001437749-26-026348.md) |
| Total liabilities | $m | [2,581](/filings/0001437749-23-030040.md) | [2,588](/filings/0001437749-25-007226.md) | [2,561](/filings/0001437749-24-014351.md) | [2,557](/filings/0001437749-24-024247.md) | [2,557](/filings/0001437749-24-033826.md) | [2,482](/filings/0001437749-26-008446.md) | [2,478](/filings/0001437749-25-015124.md) | [2,492](/filings/0001437749-25-025103.md) | [2,505](/filings/0001437749-25-033373.md) | [2,532](/filings/0001437749-26-026348.md) | [3,460](/filings/0001437749-26-015924.md) | [3,442](/filings/0001437749-26-026348.md) |
| Long-term debt | $m | not reported | [9.8](/filings/0001437749-24-006962.md) | not reported | not reported | not reported | [9.8](/filings/0001437749-25-007226.md) | not reported | not reported | not reported | [9.8](/filings/0001437749-26-008446.md) | not reported | not reported |
| Shareholders' equity | $m | [209](/filings/0001437749-24-033826.md) | [227](/filings/0001437749-26-008446.md) | [227](/filings/0001437749-25-025103.md) | [230](/filings/0001437749-25-033373.md) | [246](/filings/0001437749-25-033373.md) | [241](/filings/0001437749-26-026348.md) | [252](/filings/0001437749-26-026348.md) | [256](/filings/0001437749-26-026348.md) | [295](/filings/0001437749-25-033373.md) | [301](/filings/0001437749-26-026348.md) | [415](/filings/0001437749-26-026348.md) | [420](/filings/0001437749-26-026348.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.7 d](/filings/0001437749-24-033826.md) | [0.3 d](/filings/0001437749-26-008446.md) | [7.8](/filings/0001437749-25-015124.md) | [2.8 d](/filings/0001437749-25-025103.md) | [5.6 d](/filings/0001437749-25-033373.md) | [(0.3) d](/filings/0001437749-26-008446.md) | [4.5](/filings/0001437749-26-015924.md) | [3.2 d](/filings/0001437749-26-026348.md) | [6.9 d](/filings/0001437749-25-033373.md) | [3.6 d](/filings/0001437749-26-008446.md) | [9.9](/filings/0001437749-26-015924.md) | [6.4 d](/filings/0001437749-26-026348.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1.0 d](/filings/0001437749-24-033826.md) | [1.0 d](/filings/0001437749-26-008446.md) | [1.0](/filings/0001437749-25-015124.md) | [1.0 d](/filings/0001437749-25-025103.md) | [1.0 d](/filings/0001437749-25-033373.md) | [1.0 d](/filings/0001437749-26-008446.md) | [1.0](/filings/0001437749-26-015924.md) | [1.0 d](/filings/0001437749-26-026348.md) | [1.1 d](/filings/0001437749-25-033373.md) | [1.1 d](/filings/0001437749-26-008446.md) | [1.1](/filings/0001437749-26-015924.md) | [1.5 d](/filings/0001437749-26-026348.md) |
| Share repurchases | $m | [0.7 d](/filings/0001437749-24-033826.md) | [0.3 d](/filings/0001437749-26-008446.md) | [0.2](/filings/0001437749-25-015124.md) | [0.1 d](/filings/0001437749-25-025103.md) | [0.0 d](/filings/0001437749-25-033373.md) | [0.0 d](/filings/0001437749-26-008446.md) | [0.6](/filings/0001437749-26-015924.md) | [0.6 d](/filings/0001437749-26-026348.md) | [0.3 d](/filings/0001437749-25-033373.md) | [0.7 d](/filings/0001437749-26-008446.md) | [1.5](/filings/0001437749-26-015924.md) | [0.8 d](/filings/0001437749-26-026348.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.1](/filings/0001437749-23-030040.md) | [10.0](/filings/0001437749-24-014351.md) | [9.9](/filings/0001437749-24-024247.md) | [9.8](/filings/0001437749-24-033826.md) | [9.9](/filings/0001437749-25-015124.md) | [9.9](/filings/0001437749-25-025103.md) | [9.9](/filings/0001437749-25-033373.md) | [10.0](/filings/0001437749-26-015924.md) | [10.0](/filings/0001437749-26-026348.md) | [11.5](/filings/0001437749-25-033373.md) | [15.6](/filings/0001437749-26-015924.md) | [15.5](/filings/0001437749-26-026348.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,777,026 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026348.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.